Researchers found that PSA levels are more predictive of three-year prostate cancer risk in African-American men compared to Caucasian men with a family history. The study's findings suggest that PSA levels may be used to identify high-risk patients for earlier screening.
Researchers found that combining DHEA with red clover isoflavones increased testosterone production and reversed androgenic effects in prostate cells. The study suggests a potential cancer prevention effect of herbal supplements like DHEA, warranting further research.
A study found that rural physicians in Arizona estimated they could increase their endoscopic procedures by 53.1%, while urban physicians estimated an additional 35.7% with improved compensation. The potential increase is attributed to the growing population of older individuals moving to warmer climates.
A study by Michigan State University found that higher medical mistrust among minority women led to late breast cancer screening. The AACR is working to address these issues through research and education. Recruiting diverse patients into clinical trials also poses challenges, with incentives often not effective.
Scientists tested atorvastatin and lovastatin in animal models but found no efficacy in preventing breast cancer. In contrast, tamoxifen and bexarotene showed significant reduction in mammary tumors when combined with statins.
The ELLA Binational Breast Cancer Study reveals significant differences in breast cancer risk factors between Hispanic and non-Hispanic women. Hispanic women are at a higher risk of triple-negative breast cancer due to family history, while those born in Mexico exhibit increased risk due to geography and environment.
More than a million cancer survivors in the US are forgoing necessary medical care due to financial constraints. Minority groups, particularly Hispanics and African-Americans, face significant barriers to accessing affordable care, affecting dental care, prescription medication, and mental health services.
Despite high awareness, African-Americans are underrepresented in HPV vaccination due to misinformation, lack of education, and societal pressures. The survey found that most participants believed the vaccine was safe and effective, but caregivers were often unaware of its benefits.
Research suggests that genetic variations in DNA repair patterns can predict a threefold increased risk of pancreatic cancer, while others may decrease it by up to 77 percent. The study analyzed nine single nucleotide polymorphisms among patients with and without pancreatic cancer.
Researchers identified anthocyanins in black raspberries as effective in preventing esophageal cancer in rats. The study demonstrates the importance of anthocyanins as preventive agents in black raspberries and validates similar in vitro findings.
A study by researchers from the University of Kentucky found that grape-seed extract induces apoptosis in leukemia cells by activating the JNK pathway, leading to cell cycle regulation and death. The extract has shown promise as a potential agent for preventing or treating hematological malignancies.
Researchers found that silencing of a crucial gene in lung cancer leads to impairment in genome-wide changes, contributing to cancer development and progression. Tobacco use is strongly linked to modification of the MTHFR gene, which triggers global hypomethylation and deregulation of DNA synthesis.
Studies show hormone supplements, such as estrogen-progestin and letrozole, can reduce breast cancer mortality risk by up to 63% and improve overall survival. Meanwhile, tamoxifen is found to be superior for quality of life measures, with patients paying a price in quality of life when switching from anastrozole.
Researchers discover new biomarkers that can predict breast cancer risk, respond to tamoxifen treatment, and identify patients who may benefit from anthracycline chemotherapy. A genetic model also improves diagnostic accuracy in high-risk populations.
Easton's work on BRCA1 and BRCA2 gene mutations has significantly impacted breast cancer research. He established the Breast Cancer Linage Consortium, providing estimates of breast and ovarian cancer risk in BRCA1 mutation carriers.
Researchers are studying new treatments, including zoledronic acid, aromatase inhibitors and monoclonal antibodies, with encouraging results. Exemestane has been shown to be more effective in postmenopausal women than current treatment with tamoxifen.
A study published in Cancer Prevention Research suggests that selenium may aid in the prevention of high-risk bladder cancer. Women, moderate smokers, and those with p53 positive bladder cancer had significant reductions in bladder cancer with higher rates of selenium.
Joan Massagué was honored with the inaugural AACR Distinguished Leadership Award in Breast Cancer Research for his work on transforming growth hormone factor-Beta and its role in metastasis. His research identified organ-specific metastatic characteristics that predict cancer cell spread.
Lapatinib shows improved progression-free survival for women with HER2-positive metastatic breast cancer compared to chemotherapy alone. However, high-volume laboratories misclassify some patients, preventing them from receiving optimal therapy.
A recent study published in Cancer Research found that Latina women with higher European ancestry are at a greater risk of developing breast cancer. The risk increases by 79% for every 25% increase in European ancestry, regardless of other factors.
ER/PR negative tumors associated with higher risk of poorer prognosis and limited treatment options. African-American women have higher risk due to race, socioeconomic characteristics and other tumor characteristics.
Researchers found that home-based diet and exercise interventions improved physical functioning in older, long-term cancer survivors. Participants in the intervention group demonstrated significant improvements in their diet and exercise behaviors, as well as measures of basic and advanced lower extremity functioning.
A meta-analysis published by the American Association for Cancer Research found that individuals with HIV have a higher risk of non-AIDS cancers compared to the general population. The risk is significantly higher for men than women, and incidence rates are similar between those with AIDS and without.
A recent study found that individuals with lower socioeconomic status are more likely to be diagnosed with late-stage colorectal cancer, leading to poorer survival rates. The research highlights the importance of removing barriers to healthcare services, including screening tests and treatment for colorectal cancer.
Researchers found that calorie restriction and exercise can modify pathways leading to mTOR, a molecule involved in cell growth. Calorie restriction showed more global effects on cell signaling, suggesting it may produce a more potent anti-cancer effect.
A study published by the American Association for Cancer Research found that cruciferous vegetables like broccoli may lower lung cancer risk in smokers. The study showed a significant protective effect, with risks ranging from 20% to 55% depending on the type and duration of smoking.
A program called Project Early Awareness teaches high school girls about breast health and self-exams, resulting in a 39% increase in comfort with performing a self-exam and a 69% increase in correct answers to breast cancer questions. The goal is for breast self-exams to become routine among young women.
A recent study found that regular physical activity can lower a woman's overall risk of cancer, but only if she gets a good night's sleep. The study, published by the American Association for Cancer Research, suggests that short duration sleep can undermine exercise's cancer prevention benefits.
Researchers have found strong links between smoking and two forms of esophageal cancer, as well as a form of stomach cancer. Drinking alcohol is strongly associated with one form of esophageal cancer, with the risk increasing fivefold for those who drink four glasses a day.
Researchers studied DNA methylation in former smokers and found differences between those with lung cancer and disease-free individuals. Altered methylation levels may explain why some former smokers develop lung cancer despite quitting smoking.
African-American men and those with a family history of prostate cancer are at higher risk due to genetic factors. Genetic markers associated with increased risk have been found to be more prevalent in these populations, suggesting they may be used for personalized screening recommendations.
Researchers found associations between lifestyle, behavioral, and demographic variables on cancer risk among the elderly, including moderate physical activities decreasing cancer risk. Tobacco consumption was also linked to lung cancer, while comorbidities increased breast and prostate cancer risk.
Research identified three genes linked to fat processing that could raise kidney cancer risk, according to a study presented at the American Association for Cancer Research. Variants of nitric oxide synthase 2A and prostaglandin-endoperoxide 2 were found to increase risk, while apolipoprotein E1 was associated with reduced risk.
A study found that women with a strong family history of breast cancer but without BRCA1 or BRCA2 mutations are at increased risk for developing the disease. These women had a four-fold higher risk than average, highlighting the importance of genetic testing and preventive measures.
A large-scale clinical trial found no significant protection against cancer from long-term vitamin E or C supplements. Researchers followed over 14,000 physicians for up to 10 years without detecting a link between these supplements and reduced cancer rates.
Researchers found that men taking aspirin had significantly lower PSA levels, especially among those with prostate cancer. However, this may affect the ability to detect early-stage prostate cancer through PSA screening.
Researchers found that DFMO treatment reduced dysplasia progression in patients with Barrett's esophagus, while also lowering putrescine levels and KLF5 expression. The study suggests a potential mechanism for the chemopreventive effects of DFMO.
A large clinical trial found that calcium supplementation reduced colorectal adenoma recurrence risk by 32% only in those with low magnesium to calcium ratio. This suggests a personalized diet/supplementation regimen considering both nutrients may be more effective than supplementing with one alone.
Researchers have identified 11 single-nucleotide polymorphisms that show a significant association with esophageal cancer. Individuals with more than four unfavorable genotypes are three times more likely to develop the disease.
A non-invasive oral rinse screening method has shown promise in detecting high-risk human papillomavirus (HPV) infections in patients with head and neck cancers. The study found that oral HPV16 infections were significantly more common among patients with HPV-positive tumors, indicating a potential link between the two.
Women experiencing severe gestational hypertension may give birth to sons with a lower risk of developing testicular cancer. Hormonal imbalances and increased levels of pregnancy-related hormones like human Chorionic Gonadotropin may contribute to this protective effect.
Frank L. Meyskens Jr., a renowned cancer prevention researcher, has received the AACR-Prevent Cancer Foundation Award for his significant contributions to the field. His work on chemoprevention, including the development of topical all-trans-retinoic acid for cervical intraepithelial neoplasia, has moved the field forward.
A study published in Cancer Research found that nicotine can promote breast tumor growth and metastasis by binding to nicotinic receptors on mammary cells. The researchers also discovered that nicotine potentiates tumorigenesis when combined with other factors.
Research found that people with H. pylori strains carrying a gene called CagA were almost half as likely to get adenocarcinoma of the esophagus. The study suggests that declining rates of H. pylori in developed populations may contribute to the increase in esophageal adenocarcinomas.
Researchers at Memorial Sloan-Kettering Cancer Center found that vitamin C supplements reduce the effectiveness of a wide range of anti-cancer drugs in laboratory cancer cells and mice. Vitamin C appears to protect mitochondria, which are essential for cell survival.
Researchers have identified five biomarkers in saliva that can confirm the presence of oral squamous cell carcinoma with 93% accuracy. The study, led by David T. Wong and Shen Hu, demonstrates a new approach for cancer biomarker discovery using saliva proteomics.
A new instrument uses multispectral imaging to analyze multiple proteins in a single cancer sample, providing more information for therapy development and personalized treatment. The technology is fast, automated, and provides a quantitative read-out of protein expression levels.
Researchers at Johns Hopkins University School of Medicine developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies.
Research finds activation of Src signaling pathway contributes to treatment resistance in some patients with triple-negative breast cancer. Inhibiting this pathway holds promise as a way to overcome resistance and improve patient outcomes.
Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumor growth in ovarian cancer. High levels of TEM1 were correlated with decreased survival rates, making it a potential screening tool for early detection.